BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 2180232)

  • 1. Salmonella-based vaccines.
    Hackett J
    Vaccine; 1990 Feb; 8(1):5-11. PubMed ID: 2180232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
    Wu Y; Chakravarty S; Li M; Wai TT; Hoffman SL; Sim BK
    J Infect Dis; 2017 Jan; 215(2):259-268. PubMed ID: 27803169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PhoP virulence regulon and live oral Salmonella vaccines.
    Miller SI; Loomis WP; Alpuche-Aranda C; Behlau I; Hohmann E
    Vaccine; 1993; 11(2):122-5. PubMed ID: 8438611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated vaccines for invasive Salmonella infections.
    Tennant SM; Levine MM
    Vaccine; 2015 Jun; 33 Suppl 3(0 3):C36-41. PubMed ID: 25902362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rpoS mutant allele of Salmonella typhi Ty2 is identical to that of the live typhoid vaccine Ty21a.
    Robbe-Saule V; Norel F
    FEMS Microbiol Lett; 1999 Jan; 170(1):141-3. PubMed ID: 9919662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines.
    Levine MM; Hone D; Tacket C; Ferreccio C; Cryz S
    Res Microbiol; 1990; 141(7-8):807-16. PubMed ID: 2101470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in vaccines against typhoid fever.
    Levine MM; Ferreccio C; Black RE; Tacket CO; Germanier R
    Rev Infect Dis; 1989; 11 Suppl 3():S552-67. PubMed ID: 2669099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.
    Simanjuntak CH; Paleologo FP; Punjabi NH; Darmowigoto R; Soeprawoto ; Totosudirjo H; Haryanto P; Suprijanto E; Witham ND; Hoffman SL
    Lancet; 1991 Oct; 338(8774):1055-9. PubMed ID: 1681365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of a typhoid-dysentery bivalent strain with typhoid ty21a and dysentery T32-Istrati strains].
    Chen QY; Jiang LJ; Kong DC; Wang BR
    Wei Sheng Wu Xue Bao; 1987 Dec; 27(4):362-8. PubMed ID: 3329424
    [No Abstract]   [Full Text] [Related]  

  • 15. Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens.
    Gentschev I; Spreng S; Sieber H; Ures J; Mollet F; Collioud A; Pearman J; Griot-Wenk ME; Fensterle J; Rapp UR; Goebel W; Rothen SA; Dietrich G
    Chemotherapy; 2007; 53(3):177-80. PubMed ID: 17347563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live bacterial vaccines and their application as carriers for foreign antigens.
    Dougan G; Smith L; Heffron F
    Adv Vet Sci Comp Med; 1989; 33():271-300. PubMed ID: 2648775
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers.
    Hohmann EL; Oletta CA; Miller SI
    Vaccine; 1996 Jan; 14(1):19-24. PubMed ID: 8821644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a.
    Cryz SJ; Fürer E; Baron LS; Noon KF; Rubin FA; Kopecko DJ
    Infect Immun; 1989 Dec; 57(12):3863-8. PubMed ID: 2807550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines for preventing typhoid fever.
    Anwar E; Goldberg E; Fraser A; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001261. PubMed ID: 24385413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live attenuated Salmonella: a paradigm of mucosal vaccines.
    Sirard JC; Niedergang F; Kraehenbuhl JP
    Immunol Rev; 1999 Oct; 171():5-26. PubMed ID: 10582163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.